Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 35 (3) , 315-317
- https://doi.org/10.1016/s0169-5002(01)00441-x
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerBritish Journal of Cancer, 2000
- A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancerLung Cancer, 2000